{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:29:33Z","timestamp":1769160573507,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s12519-014-0502-0","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T14:51:17Z","timestamp":1408027877000},"page":"262-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Placental growth factor expression is reversed by antivascular endothelial growth factor therapy under hypoxic conditions"],"prefix":"10.1007","volume":"10","author":[{"given":"Ai-Yi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Zhen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lv-Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,15]]},"reference":[{"key":"502_CR1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011;364:603\u2013615.","journal-title":"N Engl J Med"},{"key":"502_CR2","doi-asserted-by":"crossref","first-page":"F170","DOI":"10.1136\/archdischild-2011-301148","volume":"98","author":"BA Darlow","year":"2013","unstructured":"Darlow BA, Ells AL, Gilbert CE, Gole GA, Quinn GE. Are we there yet?. Bevacizumab therapy for retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed 2013;98:F170\u2013174.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"502_CR3","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.1167\/iovs.11-8479","volume":"52","author":"S Raizada","year":"2011","unstructured":"Raizada S, Kandari JA, Sabti KA. Will the BEAT-ROP study results really beat ROP?. Invest Ophthalmol Vis Sci 2011;52:9288\u20139289.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"502_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.survophthal.2010.08.006","volume":"56","author":"M Tolentino","year":"2011","unstructured":"Tolentino M. Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Surv Ophthalmol 2011;56:95\u2013113.","journal-title":"Surv Ophthalmol"},{"key":"502_CR5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3109\/02713683.2011.632108","volume":"37","author":"D Jee","year":"2012","unstructured":"Jee D, Lee WK. Inhibitory effect of intravitreal injection of bevacizumab on nerve growth factor. Curr Eye Res 2012;37:408\u2013415.","journal-title":"Curr Eye Res"},{"key":"502_CR6","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1242\/jcs.115.12.2559","volume":"115","author":"T Odorisio","year":"2002","unstructured":"Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L, et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci 2002;115:2559\u20132567.","journal-title":"J Cell Sci"},{"key":"502_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","volume":"7","author":"P Carmeliet","year":"2001","unstructured":"Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001;7:575\u2013583.","journal-title":"Nat Med"},{"key":"502_CR8","first-page":"65","volume-title":"Bull Soc Belge Ophtalmol","author":"T Bergen Van","year":"2011","unstructured":"Van Bergen T, Van de Veire S, Vandewalle E, Moons L, Stalmans I. Role of placental growth factor (PIGF) in wound healing after glaucoma filtration surgery. Bull Soc Belge Ophtalmol 2011:65\u201366."},{"key":"502_CR9","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1167\/iovs.02-1092","volume":"44","author":"JM Rakic","year":"2003","unstructured":"Rakic JM, Lambert V, Devy L, Luttun A, Carmeliet P, Claes C, et al. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 2003;44:3186\u20133193.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"502_CR10","doi-asserted-by":"crossref","first-page":"e17462","DOI":"10.1371\/journal.pone.0017462","volume":"6","author":"L Kowalczuk","year":"2011","unstructured":"Kowalczuk L, Touchard E, Omri S, Jonet L, Klein C, Valamanes F, et al. Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy. PLoS One 2011;6:e17462.","journal-title":"PLoS One"},{"key":"502_CR11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/bbrc.1999.1201","volume":"262","author":"DA Simpson","year":"1999","unstructured":"Simpson DA, Murphy GM, Bhaduri T, Gardiner TA, Archer DB, Stitt AW. Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. Biochem Biophys Res Commun 1999;262:333\u2013340.","journal-title":"Biochem Biophys Res Commun"},{"key":"502_CR12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/exer.2001.1161","volume":"74","author":"R Castellon","year":"2002","unstructured":"Castellon R, Hamdi HK, Sacerio I, Aoki AM, Kenney MC, Ljubimov AV. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp Eye Res 2002;74:523\u2013535.","journal-title":"Exp Eye Res"},{"key":"502_CR13","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1074\/jbc.271.6.3154","volume":"271","author":"Y Cao","year":"1996","unstructured":"Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, et al. Heterodimers of placenta growth factor\/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1\/KDR. J Biol Chem 1996;271:3154\u20133162.","journal-title":"J Biol Chem"},{"key":"502_CR14","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","volume":"269","author":"JE Park","year":"1994","unstructured":"Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR. J Biol Chem 1994;269:25646\u201325654.","journal-title":"J Biol Chem"},{"key":"502_CR15","doi-asserted-by":"crossref","first-page":"22272","DOI":"10.1074\/jbc.273.35.22272","volume":"273","author":"M Migdal","year":"1998","unstructured":"Migdal M, Huppertz B, Tessler S, Comforti A, Shibuya M, Reich R, et al. Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem 1998;273:22272\u201322278.","journal-title":"J Biol Chem"},{"key":"502_CR16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","volume":"9","author":"M Autiero","year":"2003","unstructured":"Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, et al. Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003;9:936\u2013943.","journal-title":"Nat Med"},{"key":"502_CR17","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/0008-5472.CAN-04-3085","volume":"66","author":"L Xu","year":"2006","unstructured":"Xu L, Cochran DM, Tong RT, Winkler F, Kashiwagi S, Jain RK, et al. Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models. Cancer Res 2006;66:3971\u20133977.","journal-title":"Cancer Res"},{"key":"502_CR18","doi-asserted-by":"crossref","first-page":"10840","DOI":"10.1158\/0008-5472.CAN-07-1034","volume":"67","author":"T Schomber","year":"2007","unstructured":"Schomber T, Kopfstein L, Djonov V, Albrecht I, Baeriswyl V, Strittmatter K, et al. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis. Cancer Res 2007;67:10840\u201310848.","journal-title":"Cancer Res"},{"key":"502_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1535-6108(02)00028-4","volume":"1","author":"A Eriksson","year":"2002","unstructured":"Eriksson A, Cao R, Pawliuk R, Berg SM, Tsang M, Zhou D, et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PIGF-1\/VEGF heterodimers. Cancer Cell 2002;1:99\u2013108.","journal-title":"Cancer Cell"},{"key":"502_CR20","doi-asserted-by":"crossref","first-page":"17069","DOI":"10.1073\/pnas.0708148104","volume":"104","author":"JM Ebos","year":"2007","unstructured":"Ebos JM, Lee CR, Christensen JG, Mutsaers AJ, Kerbel RS. Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy. Proc Natl Acad Sci U S A 2007;104:17069\u201317074.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"502_CR21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1158\/1078-0432.CCR-10-2687","volume":"17","author":"RG Bagley","year":"2011","unstructured":"Bagley RG, Ren Y, Weber W, Yao M, Kurtzberg L, Pinckney J, et al. Placental growth factor upregulation is a host response to antiangiogenic therapy. Clin Cancer Res 2011;17:976\u2013988.","journal-title":"Clin Cancer Res"},{"key":"502_CR22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ophtha.2010.08.008","volume":"118","author":"M Zhang","year":"2011","unstructured":"Zhang M, Zhang J, Yan M, Luo D, Zhu W, Kaiser PK, et al. A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration. Ophthalmology 2011;118:672\u2013678.","journal-title":"Ophthalmology"},{"key":"502_CR23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1167\/iovs.05-0702","volume":"47","author":"H Gao","year":"2006","unstructured":"Gao H, Pennesi ME, Qiao X, Iyer MN, Wu SM, Holz ER, et al. Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models. Invest Ophthalmol Vis Sci 2006;47:1606\u20131611.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"502_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000072143","volume":"35","author":"WZ Yu","year":"2003","unstructured":"Yu WZ, Li XX, She HC, He PY, Dong JQ, Rui M, et al. Gene transfer of kringle 5 of plasminogen by electroporation inhibits corneal neovascularization. Ophthalmic Res 2003;35:239\u2013246.","journal-title":"Ophthalmic Res"},{"key":"502_CR25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/jpet.112.192575","volume":"342","author":"YJ Bai","year":"2012","unstructured":"Bai YJ, Huang LZ, Xu XL, Du W, Zhou AY, Yu WZ, et al. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization. J Pharmacol Exp Ther 2012;342:131\u2013139.","journal-title":"J Pharmacol Exp Ther"},{"key":"502_CR26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1073\/pnas.0911661107","volume":"107","author":"R Cao","year":"2010","unstructured":"Cao R, Xue Y, Hedlund EM, Zhong Z, Tritsaris K, Tondelli B, et al. VEGFR1-mediated pericyte ablation links VEGF and PIGF to cancer-associated retinopathy. Proc Natl Acad Sci U S A 2010;107:856\u2013861.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"502_CR27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1167\/iovs.02-0040","volume":"44","author":"SA Feeney","year":"2003","unstructured":"Feeney SA, Simpson DA, Gardiner TA, Boyle C, Jamison P, Stitt AW. Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression. Invest Ophthalmol Vis Sci 2003;44:839\u2013847.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"502_CR28","doi-asserted-by":"crossref","first-page":"H547","DOI":"10.1152\/ajpheart.00616.2005","volume":"290","author":"F Baffert","year":"2006","unstructured":"Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, Hu-Lowe D, et al. Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 2006;290:H547\u2013559.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"502_CR29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","volume":"131","author":"C Fischer","year":"2007","unstructured":"Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, et al. Anti-PIGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 2007;131:463\u2013475.","journal-title":"Cell"},{"key":"502_CR30","doi-asserted-by":"crossref","first-page":"re1","DOI":"10.1126\/scisignal.262tr1","volume":"2","author":"Y Cao","year":"2009","unstructured":"Cao Y. Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal 2009;2:re1.","journal-title":"Sci Signal"},{"key":"502_CR31","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1172\/JCI119069","volume":"98","author":"Y Cao","year":"1996","unstructured":"Cao Y, Linden P, Shima D, Browne F, Folkman J. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor\/vascular endothelial growth factor. J Clin Invest 1996;98:2507\u20132511.","journal-title":"J Clin Invest"},{"key":"502_CR32","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1096\/fj.05-5137fje","volume":"20","author":"B Li","year":"2006","unstructured":"Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, et al. VEGF and PIGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006;20:1495\u20131497.","journal-title":"FASEB J"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-014-0502-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-014-0502-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-014-0502-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T13:27:28Z","timestamp":1649942848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-014-0502-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["502"],"URL":"https:\/\/doi.org\/10.1007\/s12519-014-0502-0","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}